Cargill Wants to Brew GHB Byproduct: Party or Peril?
Published Date: 9/28/2026
Notice
Summary
Cargill, Incorporated wants to become a registered bulk maker of a controlled substance called Gamma Hydroxybutyric Acid (GHB), which will show up as a byproduct while they produce butanediol for industrial use. People and companies involved with these substances can share their thoughts or ask for a hearing by November 27, 2026. This move mainly affects manufacturers and regulators, with no direct cost changes announced yet.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-19803, Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Irvine Labs, Inc. wants to become a big-time maker of some powerful controlled substances like LSD and psilocybin for research. People and companies affected can share their thoughts or ask for a hearing by November 27, 2026. This move could boost scientific studies but won’t impact prices or public use right now.
2026-19792, Importer of Controlled Substances Application: Benuvia Operations, LLC
Benuvia Operations, LLC wants to import a special drug called Ibogaine for research and future medicine testing. People who make or use this drug can share their thoughts or ask for a hearing by October 28, 2026. This move helps Benuvia develop new treatments but doesn’t allow selling finished medicines yet.
2026-19538, Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Cambridge Isotope Laboratories wants to make a lot of a special drug called Tetrahydrocannabinols for testing purposes. People who already make or use this drug can share their thoughts by December 23, 2026, and ask for a hearing by November 23, 2026. This move could help scientists get better testing materials without changing how the drug is used.
Previous / Next Documents
Previous: 2026-19794, Request Notice: Use of Foreign-Built Small Passenger Vessel in United States Coastwise Trade, M/V NAIAD
The U.S. Department of Transportation is asking for your thoughts on letting a foreign-built small passenger boat, the M/V NAIAD, operate in U.S. coastal waters carrying up to 12 passengers. They want to make sure this won’t hurt American boat builders or businesses using U.S.-built vessels. If you have opinions, send them in by October 28, 2026!
Next: 2026-19796, Notice of Public Meeting of the Oregon Advisory Committee to the U.S. Commission on Civil Rights
The Oregon Advisory Committee to the U.S. Commission on Civil Rights is hosting a public Zoom meeting on October 15, 2026, from 1-3 PM Pacific Time to hear from the community on important civil rights issues. Anyone interested can join for free, share their thoughts, and submit written comments within 30 days after the meeting. This is a great chance for Oregon residents to have their voices heard without leaving home!